Eligibility criteria
Condition
Major Depressive Disorder
Sex
Females and Males
Age
18-75 years
Inclusion criteria
Show details
- Outpatients
- Sexually active women participating in the study must use a medically acceptable form
of contraception
- Subjects must have a primary diagnosis of major depressive disorder
Exclusion criteria
Show details
- Treatment with DVS-233 SR at any time in the past
- Treatment with venlafaxine (immediate release [IR] or extended release [ER]) within 90
days of study day 1
- Known hypersensitivity to venlafaxine (IR or ER)